Chest computed tomography and lung function one year following COVID-19 pneumonia

Article Sidebar

29-Aug-5671.pdf
Published Sep 30, 2024
DOI: https://doi.org/10.18103/mra.v12i9.5671

Downloads

Download data is not yet available.

Submit your own article

Register as an author to reserve your spot in the next issue of the Medical Research Archives.

Author Registration

Join the Society

The European Society of Medicine is more than a professional association. We are a community. Our members work in countries across the globe, yet are united by a common goal: to promote health and health equity, around the world.

Join Europe’s leading medical society and discover the many advantages of membership, including free article publication.

Membership

Main Article Content

Marie Pierre Debray
AP-HP, Service de radiologie, Hôpital Bichat, Paris, France ; Inserm UMR 1152, Paris, France
Pauline Balagny
AP-HP, Service de Physiologie Explorations Fonctionnelles, Hôpital Bichat, Paris, France; Université Paris Cité, Population-based Cohorts Unit, INSERM, Paris Saclay University, Université de Versailles Saint-Quentin-en-Yvelines, UMS 011, Paris
Camille Taille
Inserm UMR 1152, Paris, France;  Université Paris-Cité, UFR de Médecine, Paris, France; AP-HP, Service de pneumologie, Centre de référence des Maladies Pulmonaires Rares, Hôpital Hospital, Paris, France
Sacha Rozencwajg
Université Paris-Cité, UFR de Médecine, Paris, France; Hôpital Bichat, AP-HP, Département d’Anesthésie et de Réanimation, Paris, France 
Etienne de Montmollin
AP-HP, Medical and Infectious Diseases Intensive Care Unit, Bichat Hospital, Paris, France; UMR 1137, IAME, Université Paris Cité, Paris, France
Lynn Ezzeddine
AP-HP, Service de radiologie, Hôpital Bichat, Paris, France
Christophe Rioux
AP-HP, Service des Maladies Infectieuses et Tropicales, Hôpital Bichat, Paris, France
Josephine Landauer
AP-HP, Service de radiologie, Hôpital Bichat, Paris, France
Jade Ghosn
UMR 1137, IAME, Université Paris Cité, Paris, France; AP-HP, Service des Maladies Infectieuses et Tropicales, Hôpital Bichat, Paris, France
Catherine Bancal
AP-HP, Service de Physiologie Explorations Fonctionnelles, Hôpital Bichat, Paris, France
Antoine Khalil
AP-HP, Service de radiologie, Hôpital Bichat, Paris, France; Inserm UMR 1152, Paris, France; Université Paris-Cité, UFR de Médecine, Paris, France

Abstract

Objectives: To characterise chest CT abnormalities one year following severe-to-critical COVID-19 pneumonia, assess their functional significance and analyse the time-course of CT signs.


Methods: Retrospective observational monocentric study. Chest CT analysis of residual pulmonary opacities in patients having one year follow-up CT (between February 2021 and February 2022) after severe-to-critical COVID-19 pneumonia. Opacities were categorized into fibrotic-like and predominant ground-glass opacities and compared to pulmonary function tests. Sequential analysis of decreasing, stable or increasing signs at 3, 6, 12 and up to 24 months.


Results: One-year pulmonary opacities were present in 46 out of the 66 included patients, and were more frequent in patients admitted as compared to those not admitted to the intensive care unit (38/48, 79% versus 8/18, 44%, p=0.006), with an extent correlated to the length of ICU stay. Pulmonary function tests abnormalities were present in 24/29 patients (82.8%) having fibrotic-like residual opacities versus 6/13 patients (46.1%) having predominant ground-glass opacities (p=0.015). Bronchial distortions decreased in 29% of patients between 6 and 12 months, but CT abnormalities remained mostly stable thereafter in the 16 patients having follow-up CT up to 2 years.


Conclusion: One-year pulmonary opacities are more frequent in patients admitted to ICU as compared to non-ICU patients following severe-to-critical COVID-19 and seem related to the length of ICU stay. Fibrotic-like residual opacities are frequently associated to functional impairment.

Article Details

How to Cite
DEBRAY, Marie Pierre et al. Chest computed tomography and lung function one year following COVID-19 pneumonia. Medical Research Archives, [S.l.], v. 12, n. 9, sep. 2024. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/5671>. Date accessed: 21 nov. 2024. doi: https://doi.org/10.18103/mra.v12i9.5671.
ABNT APA BibTeX CBE EndNote - EndNote format (Macintosh & Windows) MLA ProCite - RIS format (Macintosh & Windows) RefWorks Reference Manager - RIS format (Windows only) Turabian
Issue
Vol 12 No 9 (2024): Vol 12 No 9 (2024): September ISSUE, Issue 9, VOl.12
Section
Research Articles

The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.

 

References

1. World Health Organization 2023 data.who.int, WHO Coronavirus (COVID-19) dashboard > Cases [Dashboard]. https://data.who.int/dashboards/covid19/cases. Accessed on August 15, 2024
2. Hui DS, Wong KT, Ko FW, Tam LS, Chan DP, Woo J, et al. The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest 2005;128(4):2247-61. doi: 10.1378/chest.128.4.2247.
3. So M, Kabata H, Fukunaga K, Takagi H, Kuno T. Radiological and functional lung sequelae of COVID-19: a systematic review and meta-analysis. BMC Pulm Med 2021;21(1):97. doi: 10.1186/s12890-021-01463-0.
4. Froidure A, Mahsouli A, Liistro G, de Greef J, Belkhir L, Gérard L, et al. Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae. Respir Med 2021 May;181:106383. doi:10.1016/j.rmed.2021.106383.
5. Poitevineau T, Chassagnon G, Bouam S, Jaubert P, Cheurfa C, Regard L, et al. Computed tomography after severe COVID-19 pneumonia: findings at 6 months and beyond. ERJ Open Res 2021 Oct 25;7(4):00488-2021. doi: 10.1183/23120541.00488-2021
6. Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2023;401(10393):e21-e33. doi: 10.1016/S0140-6736(23)00810-3.
7. Li X, Shen C, Wang L, Majumder S, Zhang D, Deen MJ, et al. Pulmonary fibrosis and its related factors in discharged patients with new corona virus pneumonia: a cohort study. Respir Res 2021;22(1):203. doi: 10.1186/s12931-021-01798-6.
8. Bocchino M, Lieto R, Romano F, Sica G, Bocchini G, Muto E, et al. Chest CT-based assessment of 1-year outcomes after moderate COVID-19 pneumonia. Radiology 2022 Nov;305(2):479-485. doi: 10.1148/radiol.220019.
9. Schlemmer F, Valentin S, Boyer L, Guillaumot A, Chabot F, Dupin C, et al. Respiratory recovery trajectories after severe-to-critical COVID-19: a 1-year prospective multicentre study. Eur Respir J 2023 Apr;61(4):2201532.
doi: 10.1183/13993003.01532-2022.
10. van Raaij BFM, Stöger JL, Hinnen C, Penfornis KM, de Jong CMM, Klok FA, et al. Fibrotic-like abnormalities notably prevalent one year after hospitalization with COVID-19. Respir Med Res 2022 Nov;82:100973. doi: 10.1016/j.resmer.2022.100973.
11. Lee JH, Yim JJ, Park J. Pulmonary function and chest computed tomography abnormalities 6-12 months after recovery from COVID-19: a systematic review and meta-analysis. Respir Res 2022 Sep 6;23(1):233. doi: 10.1186/s12931-022-02163-x
12. Watanabe A, So M, Iwagami M, Fukunaga K, Takagi H, Kabata H, et al. One-year follow-up CT findings in Covid-19 patients: a systematic review and meta-analysis. Respirology 2022 Aug;27(8):605-616. doi: 10.1111/resp.14311.
13. Babar M, Jamil H, Mehta N, Moutwakil A, Duong TQ. Short- and long-term chest-CT findings after recovery from COVID-19: a systematic review and meta-analysis. Diagnostics 2024 Mar 14;14(6):621. doi: 10.3390/diagnostics14060621.
14. Travis WD, Costabel U, Hansell DM, King Jr TE, Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013 Sep 15;188(6):733-48. doi: 10.1164/rccm.201308-1483ST.
15. Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med 2022 May 1;205(9):e18-e47. doi: 10.1164/rccm.202202-0399ST.
16. Desai SR , Wells AU, Rubens MB, Evans TW, Hansell DM. Acute respiratory distress syndrome: CT abnormalities at long-term follow-up. Radiology 1999 Jan;210(1):29-35.
doi: 10.1148/radiology.210.1.r99ja2629.
17. Stanojevic S, Kaminsky DA, Miller MR, Thompson B, Aliverti A, Barjaktarevic I, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J 2022 Jul 13;60(1):2101499.
doi: 10.1183/13993003.01499-2021.
18. ARDS Definition Task Force; Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome :the Berlin Definition. JAMA 2012 ;307 :2526-33. doi: 10.1001/jama.2012.5669.
19. Han X, Fan Y, Alwalid O, Zhang X, Jia X, Zheng Y, et al. Fibrotic interstitial lung abnormalities at 1-year follow-up CT after severe COVID-19. Radiology 2021 Dec;301(3):E438-E-440. doi: 10.1148/radiol.2021210972.
20. Han X, Chen L, Fan Y, Alwalid O, Jia X, Zheng Y, et al. Longitudinal assessment of chest CT findings and pulmonary function after COVID-19 infection. Radiology 2023 Apr;307(2):e222888. doi: 10.1148/radiol.222888.
21. Price LC, Garfield B, Bloom C, Jeyin N, Nissan D, Hull JH, et al. Persistent isolated impairment of gas transfer following COVID-19 pneumonitis relates to perfusion defects on dual-energy computed tomography. ERJ Open Res 2022 Nov 28;8(4):00224-2022.
doi: 10.1183/23120541.00224-2022.
22. Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med 2013 Nov 28;369(22):2126-36. doi: 10.1056/NEJMra1208707.
23. Ravaglia C, Doglioni C, Chilosi M, Piciucchi S, Dubini A, Rossi G, et al. Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection. Eur Respir J 2022;60(4):2102411.
doi: 10.1183/13993003.02411-2021.
24. Konopka KE, Perry W, Huang T, Farver CF, Myers JL. Usual Interstitial Pneumonia is the Most Common Finding in Surgical Lung Biopsies from Patients with Persistent Interstitial Lung Disease Following Infection with SARS-CoV-2. EClinicalMedicine 2021;42:101 209. doi: 10.1016/j.eclinm.2021.101209.